Discontinued — last reported Q4 '25

Other Income & Expense

Change In Fair Value Of Warrant Liability And Contingent Earn Out Shares

Revolution Medicines, Inc. Change In Fair Value Of Warrant Liability And Contingent Earn Out Shares decreased by 2032.9% to -$12.63M in Q4 2025 compared to the prior quarter.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2021
Last reportedQ4 2025Feb 25, 2026

How to read this metric

A gain indicates a decrease in the liability value, while a loss indicates an increase in the liability, often correlated with stock price performance.

Detailed definition

This metric captures the non-cash gains or losses resulting from the periodic revaluation of warrant liabilities and con...

Peer comparison

Common for companies with complex capital structures or those that went public via SPACs.

Metric ID: other_income_expense_change_in_fair_value_of_warrant_lia_6866ca

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$115.00K$3.91M$1.91M-$1.27M$0.00$2.44M-$4.58M-$592.00K-$12.63M
QoQ Change>999%-51.2%-166.5%+100.0%-287.7%+87.1%<-999%
YoY Change-100.0%-37.5%-340.1%+53.3%
Range-$12.63M$3.91M
Avg YoY Growth-106.1%
Median YoY Growth-68.8%

Frequently Asked Questions

What is Revolution Medicines, Inc.'s change in fair value of warrant liability and contingent earn out shares?
Revolution Medicines, Inc. (RVMD) reported change in fair value of warrant liability and contingent earn out shares of -$12.63M in Q4 2025.
What does change in fair value of warrant liability and contingent earn out shares mean?
Non-cash gains or losses from changes in the value of warrants and earn-out shares.